marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2023
added 12-14-2024
Ascendis Pharma A/S Financial Statements 2011-2024 | ASND
Annual Financial Statements Ascendis Pharma A/S
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | - | 7.37 B | 8.44 B | 6.47 B | 2.57 B | 1.35 B | 561 M | 453 M | 336 M | - | - | - |
Shares |
- | - | 54.8 M | 50.6 M | 46.5 M | 41.1 M | 33.6 M | 26.6 M | 23.8 M | 16.9 M | - | - | - |
Historical Prices |
142 | 91.3 | 135 | 167 | 139 | 62.6 | 40.1 | 20.2 | 18.3 | - | - | - | - |
Net Income |
- | - | -384 M | -419 M | -218 M | -130 M | -124 M | -68.5 M | -32.9 M | -9.66 M | 4.08 M | 1.25 M | - |
Revenue |
267 M | 51.2 M | 7.78 M | 6.95 M | 13.4 M | 10.6 M | 1.53 M | 4.61 M | 8.12 M | 14 M | 20.4 M | 15.6 M | - |
Cost of Revenue |
- | - | 3.52 M | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
222 M | 39 M | 4.26 M | 6.95 M | 13.4 M | - | - | - | - | 14 M | 20.4 M | 15.6 M | - |
Operating Income |
- | - | -452 M | -331 M | -227 M | -155 M | -112 M | -72.9 M | -41.8 M | - | - | - | - |
Interest Expense |
44.1 M | 30.7 M | 3.91 M | 1.92 M | 1.22 M | 127 K | 97 K | 5 K | 6 K | - | - | - | - |
EBITDA |
- | - | -452 M | -331 M | -227 M | -155 M | -112 M | -72.2 M | -41.3 M | -11.5 M | 5.68 M | 1.94 M | - |
Operating Expenses |
- | - | - | 338 M | 240 M | 165 M | 113 M | 77.5 M | 49.9 M | 26 M | 15.1 M | 14.1 M | - |
General and Administrative Expenses |
- | - | 160 M | 76.7 M | 48.5 M | 25.1 M | 13.5 M | 11.5 M | 9.42 M | 6.27 M | 2.42 M | 2.69 M | - |
All numbers in EUR currency
Quarterly Income Statement Ascendis Pharma A/S
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | - | 56.7 M | - | 54.6 M | 53.8 M | 53.8 M | - | 52.7 M | 48.2 M | 48 M | - | 47.6 M | 47.2 M | 43.4 M | - | 41.9 M | 41.7 M | 38.7 M | - | 32.6 M | 32.5 M | 32.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
- | - | - | -125 M | - | -80.3 M | -134 M | -62.8 M | - | -122 M | -94.9 M | -63.3 M | - | -25.1 M | -58.9 M | -53.6 M | - | -34 M | -22.8 M | -41.4 M | - | -33.9 M | -30.7 M | -25.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | 6.83 M | - | 1.11 M | 1.02 M | 746 K | - | 2.76 M | 1.44 M | 2.22 M | - | 2.24 M | 3.21 M | 5.41 M | - | 20 K | 18 K | 28 K | - | 434 K | 444 K | 372 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | 4.25 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 2.58 M | - | - | - | 746 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | -128 M | - | -96.9 M | -118 M | -125 M | - | -78.8 M | -82.9 M | -73.2 M | - | -54 M | -51.6 M | -56.3 M | - | -38.3 M | -45.4 M | -35.2 M | - | -31.5 M | -24.7 M | -23.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | -128 M | - | -96.9 M | -118 M | -125 M | - | -78.8 M | -82.9 M | -73.2 M | - | -54 M | -51.6 M | -56.3 M | - | -38.3 M | -45.4 M | -35.2 M | - | -31.5 M | -24.7 M | -23.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | - | 47.4 M | - | 39.3 M | 35.3 M | 37.2 M | - | 17.5 M | 20.8 M | 17.9 M | - | 10 M | 11 M | 10.4 M | - | 6.8 M | 5.23 M | 4.66 M | - | 2.84 M | 3.23 M | 3.32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in EUR currency